Literature DB >> 9624530

Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer.

J Adélaïde1, M Chaffanet, A Imbert, F Allione, J Geneix, C Popovici, D van Alewijk, J Trapman, R Zeillinger, A L Børresen-Dale, R Lidereau, D Birnbaum, M J Pébusque.   

Abstract

Several genes, most of them unknown, of the short arm of chromosome 8 are involved in malignant diseases. Numerous studies have implicated a portion of the 8p11-p21 region as the location of one or more tumor suppressor genes involved in a variety of human cancers, including breast cancer. We and others have reported linkage analyses suggesting the presence of a putative breast cancer susceptibility gene. Furthermore, several oncogenes of the 8p11-p12 region are involved in reciprocal translocations in myeloproliferative and myelodysplastic disorders and in amplification in breast cancer. To facilitate the analysis of the 8p11-p21 region and the cloning of candidate oncogenes and tumor suppressor genes, a high-resolution physical and transcriptional map was established with 39 yeast artificial chromosomes and 94 markers, including so-called sequence-tagged sites and expressed sequence-tagged sites derived from either known genes or expressed sequence tags corresponding to unidentified transcripts. In addition, four novel transcripts were identified and localized precisely within the map. This transcription map provides a detailed description of gene order for the 8p11-p21 region and will be helpful in the identification of candidate genes for diseases. From this basis, we refined the mapping of two types of molecular alterations that occur at 8p11-p21 in sporadic breast cancers, i.e., amplification and deletion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624530     DOI: 10.1002/(sici)1098-2264(199807)22:3<186::aid-gcc4>3.0.co;2-s

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  15 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).

Authors:  Jin Qi; Lei Huo; Yiwei Tony Zhu; Yi-Jun Zhu
Journal:  J Biol Chem       Date:  2014-09-25       Impact factor: 5.157

3.  Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3.

Authors:  Brittany Turner-Ivey; Ericka L Smith; Alex C Rutkovsky; Laura S Spruill; Jamie N Mills; Stephen P Ethier
Journal:  Breast Cancer Res Treat       Date:  2017-05-08       Impact factor: 4.872

Review 4.  The pur protein family: genetic and structural features in development and disease.

Authors:  Edward M Johnson; Dianne C Daniel; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2013-05       Impact factor: 6.384

5.  A sparse Ising model with covariates.

Authors:  Jie Cheng; Elizaveta Levina; Pei Wang; Ji Zhu
Journal:  Biometrics       Date:  2014-08-05       Impact factor: 2.571

6.  Analysis of DLC-1 expression in human breast cancer.

Authors:  Marlies Plaumann; Susanne Seitz; Renate Frege; Lope Estevez-Schwarz; Siegfried Scherneck
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-21       Impact factor: 4.553

7.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

8.  Aberrations of TACC1 and TACC3 are associated with ovarian cancer.

Authors:  Brenda Lauffart; Mary M Vaughan; Roger Eddy; David Chervinsky; Richard A DiCioccio; Jennifer D Black; Ivan H Still
Journal:  BMC Womens Health       Date:  2005-05-26       Impact factor: 2.809

9.  Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.

Authors:  Anne Letessier; Fabrice Sircoulomb; Christophe Ginestier; Nathalie Cervera; Florence Monville; Véronique Gelsi-Boyer; Benjamin Esterni; Jeannine Geneix; Pascal Finetti; Christophe Zemmour; Patrice Viens; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; Daniel Birnbaum; Max Chaffanet
Journal:  BMC Cancer       Date:  2006-10-13       Impact factor: 4.430

10.  Gamma-heregulin has no biological significance in primary breast cancer.

Authors:  E A Sánchez-Valdivieso; J J Cruz; R Salazar; M del Mar Abad; A Gómez-Alonso; A Gómez; R González-Sarmiento
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.